These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

825 related items for PubMed ID: 19726039

  • 21. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D, De Cicco S, Tagliaferri V, Proto C, Lanzone A, Guido M.
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [Abstract] [Full Text] [Related]

  • 22. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A.
    Endokrynol Pol; 2011 May; 62(2):120-8. PubMed ID: 21528473
    [Abstract] [Full Text] [Related]

  • 23. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S, Andarieh MG, Ghadimi R, Delavar MA.
    Glob J Health Sci; 2014 Sep 28; 7(2):101-6. PubMed ID: 25716399
    [Abstract] [Full Text] [Related]

  • 24. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C, Fanelli F, Castelli S, Mezzullo M, Altieri P, Corzani F, Pelusi C, Repaci A, Di Dalmazi G, Vicennati V, Baldazzi L, Menabò S, Dormi A, Nardi E, Brillanti G, Pasquali R, Pagotto U, Gambineri A.
    J Endocrinol Invest; 2020 Oct 28; 43(10):1499-1509. PubMed ID: 32236851
    [Abstract] [Full Text] [Related]

  • 25. Results of the ACTH stimulation test in hirsute women.
    Erel CT, Senturk LM, Oral E, Mutlu H, Colgar U, Seyisoglu H, Ertungealp E.
    J Reprod Med; 1999 Mar 28; 44(3):247-52. PubMed ID: 10202742
    [Abstract] [Full Text] [Related]

  • 26. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov 28; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 27. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E, Kunicki M, Radowicki S.
    Ginekol Pol; 2010 Oct 28; 81(10):745-9. PubMed ID: 21117302
    [Abstract] [Full Text] [Related]

  • 28. Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease.
    Chrousos GP, Loriaux DL, Mann DL, Cutler GB.
    Ann Intern Med; 1982 Feb 28; 96(2):143-8. PubMed ID: 6977282
    [Abstract] [Full Text] [Related]

  • 29. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC, Cajdler-Luba A, Bieńkiewicz M, Lewiński A.
    Neuro Endocrinol Lett; 2011 Feb 28; 32(6):847-56. PubMed ID: 22286802
    [Abstract] [Full Text] [Related]

  • 30. Detection of functional ovarian hyperandrogenism in women with androgen excess.
    Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z.
    N Engl J Med; 1992 Jul 16; 327(3):157-62. PubMed ID: 1319000
    [Abstract] [Full Text] [Related]

  • 31. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A, Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Nov 16; 82(11):3728-33. PubMed ID: 9360532
    [Abstract] [Full Text] [Related]

  • 32. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, Al-Bahar AJ, Al-Nuaimy AA.
    Saudi Med J; 2007 Jul 16; 28(7):1039-43. PubMed ID: 17603706
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico.
    Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI, Azziz R.
    Fertil Steril; 2000 Jul 16; 74(1):59-62. PubMed ID: 10899497
    [Abstract] [Full Text] [Related]

  • 34. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
    Lobo RA, Goebelsmann U.
    Am J Obstet Gynecol; 1980 Nov 15; 138(6):720-6. PubMed ID: 6254362
    [Abstract] [Full Text] [Related]

  • 35. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls.
    Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M.
    J Clin Endocrinol Metab; 2005 Mar 15; 90(3):1347-53. PubMed ID: 15598692
    [Abstract] [Full Text] [Related]

  • 36. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
    Sagnella F, Apa R, Guido M, Villa P, Spadoni V, Miceli F, Lanzone A.
    Fertil Steril; 2009 May 15; 91(5):1857-63. PubMed ID: 18538325
    [Abstract] [Full Text] [Related]

  • 37. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R, Black VY, Knochenhauer ES, Hines GA, Boots LR.
    J Clin Endocrinol Metab; 1999 Mar 15; 84(3):946-50. PubMed ID: 10084576
    [Abstract] [Full Text] [Related]

  • 38. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism.
    Unluhizarci K, Kula M, Dundar M, Tanriverdi F, Israel S, Colak R, Dokmetas HS, Atmaca H, Bahceci M, Balci MK, Comlekci A, Bilen H, Akarsu E, Erem C, Kelestimur F.
    Gynecol Endocrinol; 2010 Feb 15; 26(2):139-43. PubMed ID: 19718570
    [Abstract] [Full Text] [Related]

  • 39. The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome.
    Trakakis E, Rizos D, Loghis C, Chryssikopoulos A, Spyropoulou M, Salamalekis E, Simeonides G, Vagopoulos V, Salamalekis G, Kassanos D.
    Endocr J; 2008 Mar 15; 55(1):33-9. PubMed ID: 18187875
    [Abstract] [Full Text] [Related]

  • 40. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI.
    J Clin Endocrinol Metab; 1999 Nov 15; 84(11):4006-11. PubMed ID: 10566641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.